Skin immune sentinels in health and disease

Nature Reviews Immunology

Volumn 9, Issue 10, 2009, Pages 679-691

  Nestle, Frank O ^a   Di Meglio, Paola ^a   Qin, Jian Zhong ^b   Nickoloff, Brian J ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN PRESENTING CELL; ATOPIC DERMATITIS; DERMIS; EPIDERMIS; HOMEOSTASIS; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOPATHOGENESIS; INNATE IMMUNITY; KERATINOCYTE; LANGERHANS CELL; LYMPHOCYTE FUNCTION; MACROPHAGE; MEMORY T LYMPHOCYTE; PRIORITY JOURNAL; PSORIASIS; REVIEW; SKIN DISEASE; SKIN FUNCTION; SKIN INFLAMMATION; T LYMPHOCYTE;

ANIMALS; DENDRITIC CELLS; DERMATITIS; HUMANS; IMMUNITY, INNATE; KERATINOCYTES; MACROPHAGES; PSORIASIS; SKIN; T-LYMPHOCYTE SUBSETS;

EID: 70349448402     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri2622     Document Type: Review

References (138)

1. Streilein, J. W. Skin-associated lymphoid tissues (SALT): origins and functions. J. Invest. Dermatol. 80, 12S-16S (1983).
2. Bos, J. D. & Kapsenberg, M. L. The skin immune system (SIS): its cellular constituents and their interactions. Immunol. Today 7, 235-240 (1986).
3. Stingl, G. & Bergstresser, P. R. Dendritic cells: a major story unfolds. Immunol. Today 16, 330-333 (1995).
4. Nickoloff, B. J. (ed.) Dermal Immune System (CRC, Boca Raton, 1993).
5. Proksch, E., Brandner, J. M. & Jensen, J. M. The skin: an indispensable barrier. Exp. Dermatol. 17, 1063-1072 (2008).
6. Krueger, G. G. & Stingl, G. Immunology/inflammation of the skin - a 50-year perspective. J. Invest. Dermatol. 92, 32S-51S (1989).
7. Janeway, C. A. Jr. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 54, 1-13 (1989).
8. Lebre, M. C. et al. Human keratinocytes express functional Toll-like receptor 3, 4, 5, and 9. J. Invest. Dermatol. 127, 331-341 (2007).
9. Kalali, B. N. et al. Double-stranded RNA induces an antiviral defense status in epidermal keratinocytes through TLR3-, PKR-, and MDA5/RIG-I-mediated differential signaling. J. Immunol. 181, 2694-2704 (2008).
10. Miller, L. S. & Modlin, R. L. Human keratinocyte Tolllike receptors promote distinct immune responses. J. Invest. Dermatol. 127, 262-263 (2007).
11. Martinon, F., Mayor, A. & Tschopp, J. The inflammasomes: guardians of the body. Annu. Rev. Immunol. 27, 229-265 (2009).
12. Feldmeyer, L. et al. The inflammasome mediates UVB-induced activation and secretion of interleukin-1β by keratinocytes. Curr. Biol. 17, 1140-1145 (2007).
13. Keller, M., Ruegg, A., Werner, S. & Beer, H. D. Active caspase-1 is a regulator of unconventional protein secretion. Cell 132, 818-831 (2008). References 12 and 13 are key papers showing that the inflammasome machinery is responsible for UV-induced secretion of IL-1β by human keratinocytes.
14. Watanabe, H. et al. Activation of the IL-1β-processing inflammasome is involved in contact hypersensitivity. J. Invest. Dermatol. 127, 1956-1963 (2007).
15. Gilliet, M. & Lande, R. Antimicrobial peptides and self-DNA in autoimmune skin inflammation. Curr. Opin. Immunol. 20, 401-407 (2008).
16. Lai, Y. & Gallo, R. L. AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol. 30, 131-141 (2009).
17. Weaver, C. T. , Hatton, R. D., Mangan, P. R. & Harrington, L. E. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 25, 821-852 (2007).
18. Liang, S. C. et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 203, 2271-2279 (2006).
19. Kolls, J. K., McCray, P. B. Jr & Chan, Y. R. Cytokine-mediated regulation of antimicrobial proteins. Nature Rev. Immunol. 8, 829-835 (2008).
20. Harder, J., Bartels, J., Christophers, E. & Schroder, J. M. A peptide antibiotic from human skin. Nature 387, 861 (1997).
21. Lande, R. et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449, 564-569 (2007).
22. Schauber, J. et al. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J. Clin. Invest. 11 7 , 803-811 (2007).
23. Peric, M. et al. IL-17A enhances vitamin D3-induced expression of cathelicidin antimicrobial peptide in human keratinocytes. J. Immunol. 181, 8504-8512 (2008).
24. Albanesi, C., Scarponi, C., Giustizieri, M. L. & Girolomoni, G. Keratinocytes in inflammatory skin diseases. Curr. Drug Targets Inflamm. Allergy 4, 329-334 (2005).
25. Arend, W. P., Palmer, G. & Gabay, C. IL-1, IL-18, and IL-33 families of cytokines. Immunol. Rev. 223, 20-38 (2008).
26. Lee, P. et al. Dynamic expression of epidermal caspase 8 simulates a wound healing response. Nature 458, 519-523 (2009).
27. Groves, R. W., Mizutani, H., Kieffer, J. D. & Kupper, T. S. Inflammatory skin disease in transgenic mice that express high levels of interleukin 1α in basal epidermis. Proc. Natl Acad. Sci. USA 92, 11874-11878 (1995).
28. Blumberg, H. et al. Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation. J. Exp. Med. 204, 2603-2614 (2007).
29. Soumelis, V. et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nature Immunol. 3, 673-680 (2002).
30. Dieu-Nosjean, M. C. et al. Macrophage inflammatory protein 3α is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors. J. Exp. Med. 192, 705-718 (2000).
31. Nickoloff, B. J. & Turka, L. A. Immunological functions of non-professional antigen-presenting cells: new insights from studies of T-cell interactions with keratinocytes. Immunol. Today 15, 464-469 (1994).
32. Gaspari, A. A. & Katz, S. I. Induction of in vivo hyporesponsiveness to contact allergens by hapten-modified Ia+ keratinocytes. J. Immunol. 147, 4155-4161 (1991).
33. Nickoloff, B. J. et al. Accessory cell function of keratinocytes for superantigens. Dependence on lymphocyte function-associated antigen-1/ intercellular adhesion molecule-1 interaction. J. Immunol. 150, 2148-2159 (1993).
34. Black, A. P. et al. Human keratinocyte induction of rapid effector function in antigen-specific memory CD4+ and CD8+ T cells. Eur. J. Immunol. 37, 1485-1493 (2007).
35. Griffiths, C. E. & Nickoloff, B. J. Keratinocyte intercellular adhesion molecule-1 (ICAM-1) expression precedes dermal T lymphocytic infiltration in allergic contact dermatitis (Rhus dermatitis). Am. J. Pathol. 135, 1045-1053 (1989).
36. Kupper, T. S. The activated keratinocyte: a model for inducible cytokine production by non-bone marrow-derived cells in cutaneous inflammatory and immune responses. J. Invest. Dermatol. 94, 146S-150S (1990).
37. Luger, T. A. & Schwarz, T. Evidence for an epidermal cytokine network. J. Invest. Dermatol. 95, 100S-104S (1990).
38. Barker, J. N., Mitra, R. S., Griffiths, C. E., Dixit, V. M. & Nickoloff, B. J. Keratinocytes as initiators of inflammation. Lancet 337, 211-214 (1991).
39. Mehling, A. et al. Overexpression of CD40 ligand in murine epidermis results in chronic skin inflammation and systemic autoimmunity. J. Exp. Med. 194, 615-628 (2001).
40. Zenz, R. et al. Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature 437, 369-375 (2005).
41. Pasparakis, M. et al. TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2. Nature 417, 861-866 (2002).
42. Eckmann, L. et al. Opposing functions of IKKβ during acute and chronic intestinal inflammation. Proc. Natl Acad. Sci. USA 105, 15058-15063 (2008).
43. Sano, S. et al. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nature Med. 11 , 43-49 (2005).
44. Oppenheim, D. E. et al. Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance. Nature Immunol. 6, 928-937 (2005).
45. Strid, J. et al. Acute upregulation of an NKG2D ligand promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesis. Nature Immunol. 9, 146-154 (2008). This paper provides insights into the early phases of tissue immunosurveillance, establishing that upregulation of the NKG2D ligand RAE1α can promote considerable reorganization of the skin immune compartment.
46. Bursch, L. S. et al. Identification of a novel population of Langerin+ dendritic cells. J. Exp. Med. 204, 3147-3156 (2007).
47. Ginhoux, F. et al. Blood-derived dermal langerin+ dendritic cells survey the skin in the steady state. J. Exp. Med. 204, 3133-3146 (2007).
48. Poulin, L. F. et al. The dermis contains langerin+ dendritic cells that develop and function independently of epidermal Langerhans cells. J. Exp. Med. 204, 3119-3131 (2007).
49. Nagao, K. et al. Murine epidermal Langerhans cells and langerin-expressing dermal dendritic cells are unrelated and exhibit distinct functions. Proc. Natl Acad. Sci. USA 106, 3312-3317 (2009).
50. Merad, M., Ginhoux, F. & Collin, M. Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nature Rev. Immunol. 8, 935-947 (2008).
51. Romani, N. et al. Epidermal Langerhans cells - changing views on their function in vivo. Immunol. Lett. 106, 119-125 (2006).
52. Hunger, R. E. et al. Langerhans cells utilize CD1a and langerin to efficiently present nonpeptide antigens to T cells. J. Clin. Invest. 11 3 , 701-708 (2004).
53. Klechevsky, E. et al. Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. Immunity 29, 497-510 (2008).
54. Stoitzner, P. et al. Langerhans cells cross-present antigen derived from skin. Proc. Natl Acad. Sci. USA 103, 7783-7788 (2006).
55. Waithman, J. et al. Skin-derived dendritic cells can mediate deletional tolerance of class I-restricted self-reactive T cells. J. Immunol. 179, 4535-4541 (2007).
56. Bedoui, S. et al. Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells. Nature Immunol. 10, 488-495 (2009).
57. Schuler, G. & Steinman, R. M. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J. Exp. Med. 161, 526-546 (1985). (Pubitemid 15142803)
58. Grabbe, S., Steinbrink, K., Steinert, M., Luger, T. A. & Schwarz, T. Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity. J. Immunol. 155, 4207-4217 (1995).
59. Kaplan, D. H., Kissenpfennig, A. & Clausen, B. E. Insights into Langerhans cell function from Langerhans cell ablation models. Eur. J. Immunol. 38, 2369-2376 (2008).
60. Allan, R. S. et al. Epidermal viral immunity induced by CD8α+ dendritic cells but not by Langerhans cells. Science 301, 1925-1928 (2003).
61. Zhao, X. et al. Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J. Exp. Med. 197, 153-162 (2003).
62. Wollenberg, A. et al. Expression and function of the mannose receptor CD206 on epidermal dendritic cells in inflammatory skin diseases. J. Invest. Dermatol. 11 8 , 327-334 (2002).
63. Bieber, T. The pro- and anti-inflammatory properties of human antigen-presenting cells expressing the high affinity receptor for IgE (FcεRI). Immunobiology 212, 499-503 (2007).
64. Guttman-Yassky, E. et al. Major differences in inflammatory dendritic cells and their products distinguish atopic dermatitis from psoriasis. J. Allergy Clin. Immunol. 11 9 , 1210-1217 (2007).
65. Kissenpfennig, A. et al. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 22, 643-654 (2005).
66. Fukunaga, A., Khaskhely, N. M., Sreevidya, C. S., Byrne, S. N. & Ullrich, S. E. Dermal dendritic cells, and not Langerhans cells, play an essential role in inducing an immune response. J. Immunol. 180, 3057-3064 (2008).
67. Auffray, C., Sieweke, M. H. & Geissmann, F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu. Rev. Immunol. 27, 669-692 (2009).
68. Lopez-Bravo, M. & Ardavin, C. In vivo induction of immune responses to pathogens by conventional dendritic cells. Immunity 29, 343-351 (2008).
69. Zaba, L. C., Fuentes-Duculan, J., Steinman, R. M., Krueger, J. G. & Lowes, M. A. Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages. J. Clin. Invest. 11 7 , 2517-2525 (2007).
70. Ochoa, M. T. , Loncaric, A., Krutzik, S. R., Becker, T. C. & Modlin, R. L. "Dermal dendritic cells" comprise two distinct populations: CD1+ dendritic cells and CD209+ macrophages. J. Invest. Dermatol. 128, 2225-2231 (2008).
71. Nestle, F. O. & Nickoloff, B. J. Deepening our understanding of immune sentinels in the skin. J. Clin. Invest. 11 7 , 2382-2385 (2007).
72. Nestle, F. O., Zheng, X. G., Thompson, C. B., Turka, L. A. & Nickoloff, B. J. Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets. J. Immunol. 151, 6535-6545 (1993).
73. Lenz, A., Heine, M., Schuler, G. & Romani, N. Human and murine dermis contain dendritic cells. Isolation by means of a novel method and phenotypical and functional characterization. J. Clin. Invest. 92, 2587-2596 (1993).
74. Larregina, A. T. et al. Dermal-resident CD14+ cells differentiate into Langerhans cells. Nature Immunol. 2, 1151-1158 (2001).
75. Angel, C. E. et al. CD14+ antigen-presenting cells in human dermis are less mature than their CD1a+ counterparts. Int. Immunol. 19, 1271-1279 (2007).
76. Boyman, O. et al. Activation of dendritic antigen-presenting cells expressing common heat shock protein receptor CD91 during induction of psoriasis. Br. J. Dermatol. 152, 1211-1218 (2005).
77. Serbina, N. V., Salazar-Mather, T. P. , Biron, C. A., Kuziel, W. A. & Pamer, E. G. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 19, 59-70 (2003).
78. Lowes, M. A. et al. Increase in TNF-α and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a). Proc. Natl Acad. Sci. USA 102, 19057-19062 (2005).
79. Blanco, P. , Palucka, A. K., Gill, M., Pascual, V. & Banchereau, J. Induction of dendritic cell differentiation by IFN-α in systemic lupus erythematosus. Science 294, 1540-1543 (2001).
80. Nestle, F. O. et al. Plasmacytoid predendritic cells initiate psoriasis through interferon-α production. J. Exp. Med. 202, 135-143 (2005). References 79 and 80 establish the functional role of pDCs and their production of IFNα in the pathogenesis of immune-mediated diseases such as systemic lupus erythematosus and psoriasis.
81. Boyman, O., Conrad, C., Tonel, G., Gilliet, M. & Nestle, F. O. The pathogenic role of tissue-resident immune cells in psoriasis. Trends Immunol. 28, 51-57 (2007).
82. van Furth, R., Nibbering, P. H., van Dissel, J. T. & Diesselhoff-den Dulk, M. M. The characterization, origin, and kinetics of skin macrophages during inflammation. J. Invest. Dermatol. 85, 398-402 (1985).
83. Clark, R. A. et al. The vast majority of CLA+ T cells are resident in normal skin. J. Immunol. 176, 4431-4439 (2006).
84. Andrew, W. & Andrew, N. V. Lymphocytes in the normal epidermis of the rat and of man. Anat. Rec. 104, 217-241 (1949).
85. Bos, J. D. et al. The skin immune system (SIS): distribution and immunophenotype of lymphocyte subpopulations in normal human skin. J. Invest. Dermatol. 88, 569-573 (1987).
86. Foster, C. A. et al. Human epidermal T cells predominantly belong to the lineage expressing alpha/beta T cell receptor. J. Exp. Med. 171, 997-1013 (1990).
87. Bos, J. D. & Kapsenberg, M. L. The skin immune system: progress in cutaneous biology. Immunol. Today 14, 75-78 (1993).
88. Mora, J. R. et al. Reciprocal and dynamic control of CD8 T cell homing by dendritic cells from skin- and gut-associated lymphoid tissues. J. Exp. Med. 201, 303-316 (2005).
89. Edele, F. et al. Cutting edge: instructive role of peripheral tissue cells in the imprinting of T cell homing receptor patterns. J. Immunol. 181, 3745-3749 (2008).
90. Sigmundsdottir, H. & Butcher, E. C. Environmental cues, dendritic cells and the programming of tissue-selective lymphocyte trafficking. Nature Immunol. 9, 981-987 (2008).
91. Di Cesare, A., Di Meglio, P. & Nestle, F. O. The IL-23/ Th17 axis in immunopathogenesis of psoriasis. J. Invest. Dermatol. 129, 1339-1350 (2009).
92. Di Cesare, A., Di Meglio, P. & Nestle, F. O. A role for Th17 cells in the immunopathogenesis of atopic dermatitis? J. Invest. Dermatol. 128, 2569-2571 (2008).
93. de Beaucoudrey, L. et al. Mutations in S TAT 3 and IL12RB1 impair the development of human IL-17-producing T cells. J. Exp. Med. 205, 1543-1550 (2008).
94. Milner, J. D. et al. Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 452, 773-776 (2008).
95. Eyerich, K. et al. Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22. J. Invest. Dermatol. 128, 2640-2645 (2008).
96. Duhen, T., Geiger, R., Jarrossay, D., Lanzavecchia, A. & Sallusto, F. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nature Immunol. 10, 857-863 (2009).
97. Trifari, S., Kaplan, C. D., Tran, E. H., Crellin, N. K. & Spits, H. Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from TH-17, TH1 and TH2 cells. Nature Immunol. 10, 864-871 (2009).
98. Nograles, K. E. et al. IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH 17 T cells. J. Allergy Clin. Immunol. 123, 1244-1252 (2009).
99. Luster, A. D., Alon, R. & von Andrian, U. H. Immune cell migration in inflammation: present and future therapeutic targets. Nature Immunol. 6, 1182-1190 (2005).
100. Kupper, T. S. & Fuhlbrigge, R. C. Immune surveillance in the skin: mechanisms and clinical consequences. Nature Rev. Immunol. 4, 211-222 (2004).
101. Boyman, O. et al. Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-α. J. Exp. Med. 199, 731-736 (2004).
102. Conrad, C. et al. a 1 (31 integrin is crucial for accumulation of epidermal T cells and the development of psoriasis. Nature Med. 13, 836-842 (2007). References 101 and 102 both use a new psoriasis xenotransplantation model to show evidence for a functional role of tissue-resident T cells in the pathogenesis of psoriasis. They also identify the binding of VLA1 on T cells to collagen IV as a key checkpoint for T cell entry into the epidermis during inflammation.
103. Wakim, L. M., Waithman, J., van Rooijen, N., Heath, W. R. & Carbone, F. R. Dendritic cell-induced memory T cell activation in nonlymphoid tissues. Science 31 9, 198-202 (2008).
104. Gebhardt, T. et al. Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus. Nature Immunol. 10, 524-530 (2009).
105. Woodland, D. L. & Kohlmeier, J. E. Migration, maintenance and recall of memory T cells in peripheral tissues. Nature Rev. Immunol. 9, 153-161 (2009).
106. Hayday, A. & Tigelaar, R. Immunoregulation in the tissues by yS T cells. Nature Rev. Immunol. 3, 233-242 (2003).
107. Kronenberg, M. Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol. 23, 877-900 (2005).
108. Bergstresser, P. R., Sullivan, S., Streilein, J. W. & Tigelaar, R. E. Origin and function of Thy-1+ dendritic epidermal cells in mice. J. Invest. Dermatol. 85, 85S-90S (1985).
109. Girardi, M. Immunosurveillance and immunoregulation by yS T cells. J. Invest. Dermatol. 126, 25-31 (2006).
110. Boyden, L. M. et al. Skint1, the prototype of a newly identified immunoglobulin superfamily gene cluster, positively selects epidermal yS T cells. Nature Genet. 40, 656-662 (2008).
111. Strid, J., Tigelaar, R. E. & Hayday, A. C. Skin immune surveillance by T cells - a new order? Semin. Immunol. 21, 110-120 (2009).
112. Girardi, M. et al. Regulation of cutaneous malignancy by yS T cells. Science 294, 605-609 (2001).
113. Girardi, M. et al. Resident skin-specific yS T cells provide local, nonredundant regulation of cutaneous inflammation. J. Exp. Med. 195, 855-867 (2002).
114. Roberts, S. J. et al. Characterizing tumor-promoting T cells in chemically induced cutaneous carcinogenesis. Proc. Natl Acad. Sci. USA 104, 6770-6775 (2007).
115. Holtmeier, W. & Kabelitz, D. yS T cells link innate and adaptive immune responses. Chem. Immunol. Allergy 86, 151-183 (2005).
116. Toulon, A. et al. A role for human skin-resident T cells in wound healing. J. Exp. Med. 206, 743-750 (2009)
117. Agerberth, B. et al. The human antimicrobial and chemotactic peptides LL-37 and a-defensins are expressed by specific lymphocyte and monocyte populations. Blood 96, 3086-3093 (2000).
118. Nickoloff, B. J. Skin innate immune system in psoriasis: friend or foe? J. Clin. Invest. 104, 1161-1164 (1999).
119. Nickoloff, B. J., Bonish, B., Huang, B. B. & Porcelli, S. A. Characterization of a T cell line bearing natural killer receptors and capable of creating psoriasis in a SCID mouse model system. J. Dermatol. Sci. 24, 2 12-225 (2000).
120. Bonish, B. et al. Overexpression of CD 1 d by keratinocytes in psoriasis and CD1d-dependent IFN-y production by NK-T cells. J. Immunol. 165, 4076-4085 (2000).
121. Gober, M. D., Fishelevich, R., Zhao, Y., Unutmaz, D. & Gaspari, A. A. Human natural killer T cells infiltrate into the skin at elicitation sites of allergic contact dermatitis. J. Invest. Dermatol. 128, 1460-1469 (2008).
122. Gorbachev, A. V. & Fairchild, R. L. Activated NKT cells increase dendritic cell migration and enhance CD8+ T cell responses in the skin. Eur. J. Immunol. 36, 2494-2503 (2006).
123. Grabbe, S. & Schwarz, T. I mmu no regulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Immunol. Today 19, 37-44 (1998).
124. Gober, M. D. & Gaspari, A. A. Allergic contact dermatitis. Curr. Dir. Autoimmun. 10, 1-26 (2008).
125. Lonsdorf, A. S. & Enk, A. H. Immunologie des allergischen kontaktekzems. Hautarzt 60, 32-41 (2009) (in German).
126. Martin, S. F & Jakob, T. From innate to adaptive immune responses in contact hypersensitivity. Curr. Opin. Allergy Clin. Immunol. 8, 289-293 (2008).
127. Nestle, F O., Kaplan, D. H. & Barker, J. Psoriasis. N. Engl. J. Med. 361, 496-509 (2009).
128. Ellis, C. N. et al. Cyclosporine improves psoriasis in a double-blind study. JAMA 256, 3110-3116 (1986).
129. Prinz, J. C. et al. Selection of conserved TCR VDJ rearrangements in chronic psoriatic plaques indicates a common antigen in psoriasis vulgaris. Eur. J. Immunol. 29, 3360-3368 (1999).
130. Austin, L. M., Ozawa, M., Kikuchi, T., Walters, I. B. & Krueger, J. G. The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-y, interleukin-2, and tumor necrosis factor-α, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. J. Invest. Dermatol. 11 3 , 752-759 (1999).
131. Valdimarsson, H., Baker, B. S., Jonsdottir, I., Powles, A. & Fry, L. Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal superantigens? Immunol. Today 16, 145-149 (1995).
132. Lowes, M. A., Bowcock, A. M. & Krueger, J. G. Pathogenesis and therapy of psoriasis. Nature 445, 866-873 (2007).
133. Capon, F., Munro, M., Barker, J. & Trembath, R. Searching for the major histocompatibility complex psoriasis susceptibility gene. J. Invest. Dermatol. 11 8 , 745-751 (2002).
134. de Cid, R. et al. Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis. Nature Genet. 41, 211-215 (2009).
135. Nair, R. P. et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways. Nature Genet. 41, 199-204 (2009).
136. Cargill, M. et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am. J. Hum. Genet. 80, 273-290 (2007).
137. Capon, F. et al. Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis. Hum. Genet. 122, 201-206 (2007).
138. van der Fits, L. et al. Imiquimod-induced psoriasis like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J. Immunol. 182, 5836-5845 (2009).